CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("LTIP RSUs") | −249,353 | 0 | ||
| 2025-01-07 | Cohen Steven Michael Director | Grant or award · Restricted Stock Units | +124,378 | 124,378 | ||
| 2024-11-15 | Merton Carl A Chief Financial Officer | Purchase | +26,000 | $1.36 | $35K | 26,000 |
| 2024-11-08 | Persofsky Renah Director | Option exercise | +11,958 | $1.50 | $18K | 75,348 |
| 2024-07-31 | SIMON IRWIN D President and CEO | Option exercise | +706,214 | $2.03 | $1.4M | 3,637,021 |
| 2024-07-31 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −390,537 | $2.03 | $793K | 3,246,484 |
| 2024-07-31 | SIMON IRWIN D President and CEO | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −706,214 | 0 | ||
| 2024-07-31 | Merton Carl A Chief Financial Officer | Option exercise | +93,926 | $2.03 | $191K | 703,412 |
| 2024-07-31 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −43,357 | $2.03 | $88K | 660,055 |
| 2024-07-31 | Merton Carl A Chief Financial Officer | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −93,926 | 0 | ||
| 2024-07-31 | Gendel Mitchell Global General Counsel | Option exercise | +93,926 | $2.03 | $191K | 468,218 |
| 2024-07-31 | Gendel Mitchell Global General Counsel | Shares withheld for taxes | −47,950 | $2.03 | $97K | 420,268 |
| 2024-07-31 | Gendel Mitchell Global General Counsel | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −93,926 | 0 | ||
| 2024-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise | +93,926 | $2.03 | $191K | 583,643 |
| 2024-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Shares withheld for taxes | −47,950 | $2.03 | $97K | 535,693 |
| 2024-07-31 | FALTISCHEK DENISE M Chief Strategy Officer | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −93,926 | 0 | ||
| 2024-07-30 | Persofsky Renah Director | Grant or award · Restricted Stock Units | +124,378 | 124,378 | ||
| 2024-07-30 | Merton Carl A Chief Financial Officer | Grant or award · Restricted Stock Units | +333,116 | 333,116 | ||
| 2024-07-30 | Looney Thomas P. Director | Grant or award · Restricted Stock Units | +124,378 | 124,378 | ||
| 2024-07-30 | Hopkinson David G. Director | Grant or award · Restricted Stock Units | +124,378 | 124,378 |
Page 8 of 35 · 686 trades